Brief: Corline Biomedical Q3 Pre-Tax Loss Widens To SEK 1.5 Mln
Nov 15 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q3 NET SALES SEK 362,000 VERSUS SEK 122,000 YEAR AGO
* Q3 PRE-TAX LOSS SEK 1.5 MILLION VERSUS LOSS SEK 987,000
YEAR AGO
Source text for Eikon: ID:nGNEbNnnT4
Further company coverage: CLBIO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln